関節リウマチ患者における生物学的製剤の使用と血清ADAM-17濃度の検討

ISHII SHO; HOSONUMA MASAHIRO; NISHIMI AIRI; NISHIMI SHIN'ICHIRO; TOKUNAGA TAKAHIRO; IKARI YUZO; FURUYA HIDEKAZU; WAKABAYASHI KUNINOBU; ISOZAKI TAKEO; KASAMA TSUYOSHI

Art

J-GLOBAL ID：201902260839012706 Reference number：19A2633117

関節リウマチ患者における生物学的製剤の使用と血清ADAM-17濃度の検討

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=19A2633117&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2633117&from=J-GLOBAL&jstjournalNo=L4881A") }}

Author (10)： , , , , , , , , ,
Material：
Volume： 63rd Page： 668 Publication year： Mar. 22, 2019
JST Material Number： L4881A Document type： Proceedings
Article type：会議録記事 Country of issue： Japan (JPN) Language： JAPANESE (JA)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2633117&from=J-GLOBAL&jstjournalNo=L4881A") }}

Drug therapy(=pharmacotherapy)for musculoskeletal diseases , Treatment for immunologic diseases,allergic diseases.

, , , ,

Return to Previous Page